The role of twice versus three times daily heparin dosing for thromboembolism prophylaxis in general medical patients admitted to the hospital

Aaron Holley, Christopher King*, Lisa Moores, Jeffrey L. Jackson, Andrew Shorr

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

Fingerprint

Dive into the research topics of 'The role of twice versus three times daily heparin dosing for thromboembolism prophylaxis in general medical patients admitted to the hospital'. Together they form a unique fingerprint.

Medicine & Life Sciences